Recorded on 03/05/25

TD Cowen analyst Phil Nadeau speaks with BioMarin's CEO Alexander Hardy and CFO Brian Mueller from TD Cowen's 45th Annual Health Care Conference about their vision for one of the biotech industry's fastest-growing mid-cap companies. Alexander and Brian describe how BioMarin will harness innovation to bring transformational therapies to patients while remaining commercially competitive and focused on creating value for shareholders. BioMarin has a well-defined long-term strategy, and has been uniquely transparent about its long-term financial guidance. Alexander and Brian talk about how the company is executing toward its long-term goals while working to convince skeptical investors of its opportunities and under-appreciated strengths. They provide insights into how one of biotech's next bellwethers is being built.

https://go.td.com/PodcastDisclosure